Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join Olink users, consortia, events and webinars to share insights and accelerate biomarker discovery.
Comprehensive statistical analysis & data visualization tools
Over 4,000 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Hepatology, 2021The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis
Barron‐Millar B., Ogle L., Mells G. et al.
Olink Target 96
Journal of Cancer Research and Clinical Oncology, 2021Associations of circulating mediators of inflammation, cell regulation and immune response with esophageal squamous cell carcinoma
Camargo M., Song M., Ito H. et al.
Nature Communications, 2021The geometry of clinical labs and wellness states from deeply phenotyped humans
Zimmer A., Korem Y., Rappaport N. et al.
Biofabrication, 2021Bio-instructive hydrogel expands the paracrine potency of mesenchymal stem cells
Drzeniek N., Mazzocchi A., Schlickeiser S. et al.
Science Translational Medicine, 2021Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro
Reyes M., Filbin M., Bhattacharyya R. et al.
Olink Explore 3072/384
Cell Discovery, 2021Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19
Tan Y., Zhang W., Zhu Z. et al.
European Heart Journal. Acute Cardiovascular Care, 2021Predicting outcome in acute myocardial infarction: an analysis investigating 175 circulating biomarkers
Eggers K., Lindhagen L., Baron T. et al.
PLOS ONE, 2021Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients
Kragstrup T., Singh H., Grundberg I. et al.
Nephrology Dialysis Transplantation, 2021Osteoprotegerin predicts cardiovascular events in patients treated with haemodialysis
Wu P., Glerup R., Svensson M. et al.
Vaccines, 2021Predictive Markers of Immunogenicity and Efficacy for Human Vaccines
Van Tilbeurgh M., Lemdani K., Beignon A. et al.
Leukemia, 2021STAT3 activation in large granular lymphocyte leukemia is associated with cytokine signaling and DNA hypermethylation
Kim D., Park G., Huuhtanen J. et al.
Neuro-Oncology Advances, 2021Plasma IL-8 and ICOSLG as prognostic biomarkers in glioblastoma
Holst C., Christensen I., Vitting-Seerup K. et al.
Scientific Reports, 2021Inflammation-related plasma protein levels and association with adiposity measurements in young adults
Klevebro S., Björkander S., Ekström S. et al.
ESC Heart Failure, 2021Proteomic profiling for detection of early‐stage heart failure in the community
Cauwenberghs N., Sabovčik F., Magnus A. et al.
Thrombosis Research, 2021Low admission protein C levels are a risk factor for disease worsening and mortality in hospitalized patients with COVID-19
Stanne T., Pedersen A., Gisslén M. et al.
Nature Metabolism, 2021Human plasma proteomic profiles indicative of cardiorespiratory fitness
Robbins J., Peterson B., Schranner D. et al.
Scientific Reports, 2021Effect of TNFα stimulation on expression of kidney risk inflammatory proteins in human umbilical vein endothelial cells cultured in hyperglycemia
Md Dom Z., Pipino C., Krolewski B. et al.
Olink Focus
Expert Review of Proteomics, 2021Proteomic signatures of inflammatory skin diseases: a focus on atopic dermatitis
Mikhaylov D., Del Duca E., Guttman-Yassky E.
Journal of Urology, 2021Cardiovascular Proteomics: A Post Hoc Analysis from a Phase II Randomized Clinical Trial Comparing GnRH Antagonist vs GnRH Agonist among Men with Advanced Prostate Cancer
Lifshitz K., Ber Y., Shenhar C. et al.
Alzheimer's & Dementia, 2021Large‐scale plasma proteomic profiling identifies a high‐performance biomarker panel for Alzheimer's disease screening and staging
Jiang Y., Zhou X., Ip F. et al.
4265 publications
Items per page
3621-3640 of 4265 publications